PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms
Qiaoke Ma, Bei Chen, Robert Seifert, Rui Zhou, Ling Xiao, Jinhui Yang, Axel Rominger, Kuangyu Shi, Weikai Li, Yongxiang Tang, Shuo Hu
{"title":"PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms","authors":"Qiaoke Ma, Bei Chen, Robert Seifert, Rui Zhou, Ling Xiao, Jinhui Yang, Axel Rominger, Kuangyu Shi, Weikai Li, Yongxiang Tang, Shuo Hu","doi":"10.1007/s00259-024-07065-2","DOIUrl":null,"url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Purpose</h3><p>To develop and validate a prostate-specific membrane antigen (PSMA) PET/CT based multimodal deep learning model for predicting pathological lymph node invasion (LNI) in prostate cancer (PCa) patients identified as candidates for extended pelvic lymph node dissection (ePLND) by preoperative nomograms.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>[<sup>68</sup>Ga]Ga-PSMA-617 PET/CT scan of 116 eligible PCa patients (82 in the training cohort and 34 in the test cohort) who underwent radical prostatectomy with ePLND were analyzed in our study. The Med3D deep learning network was utilized to extract discriminative features from the entire prostate volume of interest on the PET/CT images. Subsequently, a multimodal model i.e., Multi kernel Support Vector Machine was constructed to combine the PET/CT deep learning features, quantitative PET and clinical parameters. The performance of the multimodal models was assessed using final histopathology as the reference standard, with evaluation metrics including area under the receiver operating characteristic curve (AUC), calibration curve, decision curve analysis, and compared with available nomograms and PET/CT visual evaluation result.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Our multimodal model incorporated clinical information, maximum standardized uptake value (SUV<sub>max</sub>), and PET/CT deep learning features. The AUC for predicting LNI was 0.89 (95% confidence interval [CI] 0.81–0.97) for the final model. The proposed model demonstrated superior predictive accuracy in the test cohort compared to PET/CT visual evaluation result, the Memorial Sloan Kettering Cancer Center (MSKCC) and the Briganti-2017 nomograms (AUC 0.85 [95% CI 0.69-1.00] vs. 0.80 [95% CI 0.64–0.95] vs. 0.79 [95% CI 0.61–0.97] and 0.69 [95% CI 0.50–0.88], respectively). The proposed model showed similar calibration and higher net benefit as compared to the traditional nomograms.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Our multimodal deep learning model, which incorporates preoperative PSMA PET/CT imaging, shows enhanced predictive capabilities for LNI in clinically localized PCa compared to PSMA PET/CT visual evaluation result and existing nomograms like the MSKCC and Briganti-2017 nomograms. This model has the potential to reduce unnecessary ePLND procedures while minimizing the risk of missing cases of LNI.</p>","PeriodicalId":11909,"journal":{"name":"European Journal of Nuclear Medicine and Molecular Imaging","volume":"42 1","pages":""},"PeriodicalIF":7.6000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Nuclear Medicine and Molecular Imaging","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00259-024-07065-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
To develop and validate a prostate-specific membrane antigen (PSMA) PET/CT based multimodal deep learning model for predicting pathological lymph node invasion (LNI) in prostate cancer (PCa) patients identified as candidates for extended pelvic lymph node dissection (ePLND) by preoperative nomograms.
Methods
[68Ga]Ga-PSMA-617 PET/CT scan of 116 eligible PCa patients (82 in the training cohort and 34 in the test cohort) who underwent radical prostatectomy with ePLND were analyzed in our study. The Med3D deep learning network was utilized to extract discriminative features from the entire prostate volume of interest on the PET/CT images. Subsequently, a multimodal model i.e., Multi kernel Support Vector Machine was constructed to combine the PET/CT deep learning features, quantitative PET and clinical parameters. The performance of the multimodal models was assessed using final histopathology as the reference standard, with evaluation metrics including area under the receiver operating characteristic curve (AUC), calibration curve, decision curve analysis, and compared with available nomograms and PET/CT visual evaluation result.
Results
Our multimodal model incorporated clinical information, maximum standardized uptake value (SUVmax), and PET/CT deep learning features. The AUC for predicting LNI was 0.89 (95% confidence interval [CI] 0.81–0.97) for the final model. The proposed model demonstrated superior predictive accuracy in the test cohort compared to PET/CT visual evaluation result, the Memorial Sloan Kettering Cancer Center (MSKCC) and the Briganti-2017 nomograms (AUC 0.85 [95% CI 0.69-1.00] vs. 0.80 [95% CI 0.64–0.95] vs. 0.79 [95% CI 0.61–0.97] and 0.69 [95% CI 0.50–0.88], respectively). The proposed model showed similar calibration and higher net benefit as compared to the traditional nomograms.
Conclusion
Our multimodal deep learning model, which incorporates preoperative PSMA PET/CT imaging, shows enhanced predictive capabilities for LNI in clinically localized PCa compared to PSMA PET/CT visual evaluation result and existing nomograms like the MSKCC and Briganti-2017 nomograms. This model has the potential to reduce unnecessary ePLND procedures while minimizing the risk of missing cases of LNI.
目的建立并验证一种基于前列腺特异性膜抗原(PSMA) PET/CT的多模态深度学习模型,用于预测前列腺癌(PCa)患者的病理性淋巴结侵袭(LNI),前列腺癌(PCa)患者通过术前病理图确定为扩展盆腔淋巴结清扫(ePLND)的候选患者。[68Ga]Ga-PSMA-617 PET/CT扫描对116例接受根治性前列腺切除术合并ePLND的PCa患者(训练组82例,试验组34例)进行分析。利用Med3D深度学习网络从PET/CT图像上感兴趣的整个前列腺体积中提取判别特征。随后,将PET/CT深度学习特征、定量PET和临床参数相结合,构建多模态模型即多核支持向量机。以最终的组织病理学为参考标准,评价指标包括受试者工作特征曲线下面积(AUC)、校准曲线、决策曲线分析,并与现有的诺图图和PET/CT视觉评价结果进行比较。结果我们的多模态模型结合了临床信息、最大标准化摄取值(SUVmax)和PET/CT深度学习特征。最终模型预测LNI的AUC为0.89(95%置信区间[CI] 0.81-0.97)。与PET/CT视觉评估结果、纪念斯隆-凯特琳癌症中心(MSKCC)和Briganti-2017 nomogram (AUC分别为0.85 [95% CI 0.69-1.00]、0.80 [95% CI 0.64-0.95]、0.79 [95% CI 0.61-0.97]和0.69 [95% CI 0.50-0.88])相比,该模型在测试队列中显示出更高的预测准确性。与传统的模态图相比,所提出的模型具有相似的校准和更高的净效益。与PSMA PET/CT视觉评估结果和现有的MSKCC和Briganti-2017图相比,我们的多模态深度学习模型结合了术前PSMA PET/CT成像,对临床定位PCa的LNI预测能力增强。这种模式有可能减少不必要的ePLND手术,同时最大限度地降低遗漏LNI病例的风险。
期刊介绍:
The European Journal of Nuclear Medicine and Molecular Imaging serves as a platform for the exchange of clinical and scientific information within nuclear medicine and related professions. It welcomes international submissions from professionals involved in the functional, metabolic, and molecular investigation of diseases. The journal's coverage spans physics, dosimetry, radiation biology, radiochemistry, and pharmacy, providing high-quality peer review by experts in the field. Known for highly cited and downloaded articles, it ensures global visibility for research work and is part of the EJNMMI journal family.